Scout | Therapeutic Catalyst: funding for collaborative early-stage anti-cancer drug discovery

This opportunity is no longer accepting applications.

grant

Therapeutic Catalyst: funding for collaborative early-stage anti-cancer drug discovery

Therapeutic Catalyst funds exploratory drug discovery projects to validate and de-risk targets with the aim of developing novel single-agent anti-tumour therapies. Projects are collaborative between academic teams and Cancer Research Horizons’ Therapeutic Innovation drug discovery labs, with an assigned scientist supporting proposal development and regular advisory meetings while the grant-hol…

Source

Agency: Cancer Research UK

Award

Total Funding: $250,000

Award Ceiling: $250,000

Dates

Application Deadline: May 29, 2026

Eligibility

industry:research

Keywords

drug discovery

target validation

de-risking

academic-collaboration

anti-cancer

preclinical development

grant funding

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers